Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
NCT00734565
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Haemophilus Influenzae Type b
Interventions
BIOLOGICAL:
Haemophilus influenzae type b
Sponsor
Novartis Vaccines